Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 09-2009 | 12-2008 | 09-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | N/A | N/A | 974 | 974 |
| Other current assets | 0 | 0 | 1 | 0 | 25 |
| TOTAL | $33 | $1 | $1 | $1,000 | $1,000 |
| Non-Current Assets | |||||
| PPE Net | 42 | 67 | N/A | 76 | 76 |
| Intangibles | 219 | 450 | 0 | 426 | 0 |
| Other Non-Current Assets | 219 | 0 | 450 | 0 | 420 |
| TOTAL | $480 | $517 | $450 | $502 | $496 |
| Total Assets | $294 | $518 | $451 | $1,502 | $1,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 398 | 1,576 | 0 | 1,586 | 1,350 |
| Accrued Expenses | 72 | 76 | N/A | 12 | 10 |
| Other current liabilities | N/A | N/A | 340 | N/A | 230 |
| TOTAL | $3,288 | $2,529 | $340 | $2,742 | $2,742 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,288 | $2,529 | $340 | $2,742 | $2,742 |
| Shareholders' Equity | |||||
| Common Shares | 33 | 33 | N/A | 32 | 30 |
| Retained earnings | -25,765 | -22,689 | N/A | -14,909 | -14,909 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 9 |
| TOTAL | $-2,994 | $-2,011 | $N/A | $-1,240 | $-1,240 |
| Total Liabilities And Equity | $294 | $518 | $340 | $1,502 | $1,502 |